| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. | Director | Common Stock | 323,774 | $9,621,689 | $29.72 | 24 Nov 2025 | Direct |
| Stoke Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 29,747 | 03 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | 24 Nov 2025 | 1 | -$1,202,719 | 4 | Director | 26 Nov 2025, 16:06 |
| STOK | Stoke Therapeutics, Inc. | 14 Nov 2025 | 2 | -$1,092,058 | 4 | Director | 18 Nov 2025, 16:22 |
| STOK | Stoke Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 04 Jun 2025, 20:34 |
| STOK | Stoke Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:16 |
| STOK | Stoke Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:24 |
| STOK | Stoke Therapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 17:00 |
| STOK | Stoke Therapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 16:58 |